| Name | Title | Contact Details |
|---|
Alfa Wasserman is a Caldwell, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
XACT Robotics® is a privately held company focused on advancing the field of radiology by developing the world`s first and only hands-free robotic solutions that can significantly improve targeting accuracy, efficiency, and consistency in percutaneous radiology procedures. The company was founded in 2013 by Harel Gadot, a renowned entrepreneur in the MedTech robotics space, whose vision reimagined how image-guided percutaneous procedures are performed. At XACT, we embrace the philosophy of collaboration, tenacity, and extreme ownership. Our family culture empowers and inspires as we partner, develop, and execute meaningful technologies to make a difference in the lives of patients. Our company`s leadership is comprised of start-up, robotic, and disruptive technology experts with deep knowledge, vast experience and the diverse leadership skills required in the robotic market.
International Technology Industry is a Burke, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Straumann Group (SIX: STMN) is a global leader in tooth replacement and orthodontic solutions that restore smiles and confidence. It unites global and international brands that stand for excellence, innovation and quality in replacement, corrective and digital dentistry, including Straumann, Neodent, Medentika, ClearCorrect, Dental Wings, and other fully/partly owned companies and partners. In collaboration with leading clinics, institutes and universities, the Group researches, develops, manufactures and supplies dental implants, instruments, CADCAM prosthetics, biomaterials and digital solutions for use in tooth replacement and restoration or to prevent tooth loss. Headquartered in Basel, Switzerland, the Group currently employs approx. 6000 people worldwide and its products, solutions and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners.
Headquartered in Milford, Massachusetts, RenalGuard Solutions, Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets. Our newest product, RenalGuard®, has been developed to help prevent the onset of contrast-induced nephropathy (CIN) in at-risk patients undergoing certain imaging procedures. It is already approved for sale in the EU for general fluid balancing. Two investigator-sponsored European studies have demonstrated RenalGuard`s effectiveness at preventing CIN. RenalGuard is being studied in a pivotal trial in the U.S., as required for approval by the FDA. The RenalGuard System™ consists of a closed loop, software-controlled console and single-use sets that physicians and nurses use for automated matched fluid replacement to minimize over- or under-hydration of patients during medical procedures where creating and maintaining high urine outputs is beneficial.